Loading…
Genome-wide expression profiling of glioblastoma using a large combined cohort
Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering...
Saved in:
Published in: | Scientific reports 2018-10, Vol.8 (1), p.15104-12, Article 15104 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353 |
---|---|
cites | cdi_FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353 |
container_end_page | 12 |
container_issue | 1 |
container_start_page | 15104 |
container_title | Scientific reports |
container_volume | 8 |
creator | Tang, Jing He, Dian Yang, Pingrong He, Junquan Zhang, Yang |
description | Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering from GBM was still short. Discovering robust gene signatures toward better understanding of the complex molecular mechanisms leading to GBM is an important prerequisite to the identification of novel and more effective therapeutic strategies. Herein, a comprehensive study of genome-scale mRNA expression data by combining GBM and normal tissue samples from 48 studies was performed. The 147 robust gene signatures were identified to be significantly differential expression between GBM and normal samples, among which 100 (68%) genes were reported to be closely associated with GBM in previous publications. Moreover, function annotation analysis based on these 147 robust DEGs showed certain deregulated gene expression programs (e.g., cell cycle, immune response and p53 signaling pathway) were associated with GBM development, and PPI network analysis revealed three novel hub genes (RFC4, ZWINT and TYMS) play important role in GBM development. Furthermore, survival analysis based on the TCGA GBM data demonstrated 38 robust DEGs significantly affect the prognosis of GBM in OS (p |
doi_str_mv | 10.1038/s41598-018-33323-z |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6180049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2118311219</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353</originalsourceid><addsrcrecordid>eNp9kU1P3DAQhi3UClZb_kAPVSQuvQTGXxvnUgmtWkBawYWeLSd2gleJvbUTaPn1OCxsFw744tHMM-94_CL0FcMpBirOIsO8FDlgkVNKCc0fD9CMAOM5oYR82ouP0HGMa0iHk5Lh8hAdUaDAF6yYoesL43xv8gerTWb-boKJ0XqXbYJvbGddm_kmazvrq07FwfcqG-OUVVmnQmuy2veVdUan4M6H4Qv63KgumuOXe45-__p5u7zMVzcXV8vzVV5zBkNeaVGXWtdKLACYwgKAlE2FiQYwBXClNGeNqHBTCFZCs9BKpXWh4KrCnHI6Rz-2upux6o2ujRuC6uQm2F6Ff9IrK99WnL2Trb-Xi2kWK5PA9xeB4P-MJg6yt7E2Xaec8WOUBGNBMSZ4Qk_eoWs_BpfWm6iiJADp_-eIbKk6-BiDaXaPwSAnx-TWMZkck8-OycfU9G1_jV3Lqz8JoFsgppJrTfg_-wPZJzPNolc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2117920032</pqid></control><display><type>article</type><title>Genome-wide expression profiling of glioblastoma using a large combined cohort</title><source>Publicly Available Content Database</source><source>Full-Text Journals in Chemistry (Open access)</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Tang, Jing ; He, Dian ; Yang, Pingrong ; He, Junquan ; Zhang, Yang</creator><creatorcontrib>Tang, Jing ; He, Dian ; Yang, Pingrong ; He, Junquan ; Zhang, Yang</creatorcontrib><description>Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering from GBM was still short. Discovering robust gene signatures toward better understanding of the complex molecular mechanisms leading to GBM is an important prerequisite to the identification of novel and more effective therapeutic strategies. Herein, a comprehensive study of genome-scale mRNA expression data by combining GBM and normal tissue samples from 48 studies was performed. The 147 robust gene signatures were identified to be significantly differential expression between GBM and normal samples, among which 100 (68%) genes were reported to be closely associated with GBM in previous publications. Moreover, function annotation analysis based on these 147 robust DEGs showed certain deregulated gene expression programs (e.g., cell cycle, immune response and p53 signaling pathway) were associated with GBM development, and PPI network analysis revealed three novel hub genes (RFC4, ZWINT and TYMS) play important role in GBM development. Furthermore, survival analysis based on the TCGA GBM data demonstrated 38 robust DEGs significantly affect the prognosis of GBM in OS (p < 0.05). These findings provided new insights into molecular mechanisms underlying GBM and suggested the 38 robust DEGs could be potential targets for the diagnosis and treatment.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-018-33323-z</identifier><identifier>PMID: 30305647</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>38/39 ; 38/61 ; 631/1647/48 ; 631/337/2019 ; Brain cancer ; Brain tumors ; Cell cycle ; Chemotherapy ; Gene expression ; Genomes ; Glioblastoma ; Humanities and Social Sciences ; Immune response ; Medical prognosis ; Molecular modelling ; multidisciplinary ; p53 Protein ; Patients ; Prognosis ; Science ; Science (multidisciplinary) ; Signal transduction ; Surgery ; Survival analysis</subject><ispartof>Scientific reports, 2018-10, Vol.8 (1), p.15104-12, Article 15104</ispartof><rights>The Author(s) 2018</rights><rights>2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353</citedby><cites>FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353</cites><orcidid>0000-0002-4909-4939</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2117920032/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2117920032?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30305647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Jing</creatorcontrib><creatorcontrib>He, Dian</creatorcontrib><creatorcontrib>Yang, Pingrong</creatorcontrib><creatorcontrib>He, Junquan</creatorcontrib><creatorcontrib>Zhang, Yang</creatorcontrib><title>Genome-wide expression profiling of glioblastoma using a large combined cohort</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering from GBM was still short. Discovering robust gene signatures toward better understanding of the complex molecular mechanisms leading to GBM is an important prerequisite to the identification of novel and more effective therapeutic strategies. Herein, a comprehensive study of genome-scale mRNA expression data by combining GBM and normal tissue samples from 48 studies was performed. The 147 robust gene signatures were identified to be significantly differential expression between GBM and normal samples, among which 100 (68%) genes were reported to be closely associated with GBM in previous publications. Moreover, function annotation analysis based on these 147 robust DEGs showed certain deregulated gene expression programs (e.g., cell cycle, immune response and p53 signaling pathway) were associated with GBM development, and PPI network analysis revealed three novel hub genes (RFC4, ZWINT and TYMS) play important role in GBM development. Furthermore, survival analysis based on the TCGA GBM data demonstrated 38 robust DEGs significantly affect the prognosis of GBM in OS (p < 0.05). These findings provided new insights into molecular mechanisms underlying GBM and suggested the 38 robust DEGs could be potential targets for the diagnosis and treatment.</description><subject>38/39</subject><subject>38/61</subject><subject>631/1647/48</subject><subject>631/337/2019</subject><subject>Brain cancer</subject><subject>Brain tumors</subject><subject>Cell cycle</subject><subject>Chemotherapy</subject><subject>Gene expression</subject><subject>Genomes</subject><subject>Glioblastoma</subject><subject>Humanities and Social Sciences</subject><subject>Immune response</subject><subject>Medical prognosis</subject><subject>Molecular modelling</subject><subject>multidisciplinary</subject><subject>p53 Protein</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Signal transduction</subject><subject>Surgery</subject><subject>Survival analysis</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9kU1P3DAQhi3UClZb_kAPVSQuvQTGXxvnUgmtWkBawYWeLSd2gleJvbUTaPn1OCxsFw744tHMM-94_CL0FcMpBirOIsO8FDlgkVNKCc0fD9CMAOM5oYR82ouP0HGMa0iHk5Lh8hAdUaDAF6yYoesL43xv8gerTWb-boKJ0XqXbYJvbGddm_kmazvrq07FwfcqG-OUVVmnQmuy2veVdUan4M6H4Qv63KgumuOXe45-__p5u7zMVzcXV8vzVV5zBkNeaVGXWtdKLACYwgKAlE2FiQYwBXClNGeNqHBTCFZCs9BKpXWh4KrCnHI6Rz-2upux6o2ujRuC6uQm2F6Ff9IrK99WnL2Trb-Xi2kWK5PA9xeB4P-MJg6yt7E2Xaec8WOUBGNBMSZ4Qk_eoWs_BpfWm6iiJADp_-eIbKk6-BiDaXaPwSAnx-TWMZkck8-OycfU9G1_jV3Lqz8JoFsgppJrTfg_-wPZJzPNolc</recordid><startdate>20181010</startdate><enddate>20181010</enddate><creator>Tang, Jing</creator><creator>He, Dian</creator><creator>Yang, Pingrong</creator><creator>He, Junquan</creator><creator>Zhang, Yang</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4909-4939</orcidid></search><sort><creationdate>20181010</creationdate><title>Genome-wide expression profiling of glioblastoma using a large combined cohort</title><author>Tang, Jing ; He, Dian ; Yang, Pingrong ; He, Junquan ; Zhang, Yang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>38/39</topic><topic>38/61</topic><topic>631/1647/48</topic><topic>631/337/2019</topic><topic>Brain cancer</topic><topic>Brain tumors</topic><topic>Cell cycle</topic><topic>Chemotherapy</topic><topic>Gene expression</topic><topic>Genomes</topic><topic>Glioblastoma</topic><topic>Humanities and Social Sciences</topic><topic>Immune response</topic><topic>Medical prognosis</topic><topic>Molecular modelling</topic><topic>multidisciplinary</topic><topic>p53 Protein</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Signal transduction</topic><topic>Surgery</topic><topic>Survival analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Jing</creatorcontrib><creatorcontrib>He, Dian</creatorcontrib><creatorcontrib>Yang, Pingrong</creatorcontrib><creatorcontrib>He, Junquan</creatorcontrib><creatorcontrib>Zhang, Yang</creatorcontrib><collection>SpringerOpen (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Jing</au><au>He, Dian</au><au>Yang, Pingrong</au><au>He, Junquan</au><au>Zhang, Yang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genome-wide expression profiling of glioblastoma using a large combined cohort</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2018-10-10</date><risdate>2018</risdate><volume>8</volume><issue>1</issue><spage>15104</spage><epage>12</epage><pages>15104-12</pages><artnum>15104</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Glioblastomas (GBMs), are the most common intrinsic brain tumors in adults and are almost universally fatal. Despite the progresses made in surgery, chemotherapy, and radiation over the past decades, the prognosis of patients with GBM remained poor and the average survival time of patients suffering from GBM was still short. Discovering robust gene signatures toward better understanding of the complex molecular mechanisms leading to GBM is an important prerequisite to the identification of novel and more effective therapeutic strategies. Herein, a comprehensive study of genome-scale mRNA expression data by combining GBM and normal tissue samples from 48 studies was performed. The 147 robust gene signatures were identified to be significantly differential expression between GBM and normal samples, among which 100 (68%) genes were reported to be closely associated with GBM in previous publications. Moreover, function annotation analysis based on these 147 robust DEGs showed certain deregulated gene expression programs (e.g., cell cycle, immune response and p53 signaling pathway) were associated with GBM development, and PPI network analysis revealed three novel hub genes (RFC4, ZWINT and TYMS) play important role in GBM development. Furthermore, survival analysis based on the TCGA GBM data demonstrated 38 robust DEGs significantly affect the prognosis of GBM in OS (p < 0.05). These findings provided new insights into molecular mechanisms underlying GBM and suggested the 38 robust DEGs could be potential targets for the diagnosis and treatment.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>30305647</pmid><doi>10.1038/s41598-018-33323-z</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-4909-4939</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2018-10, Vol.8 (1), p.15104-12, Article 15104 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6180049 |
source | Publicly Available Content Database; Full-Text Journals in Chemistry (Open access); PubMed Central; Springer Nature - nature.com Journals - Fully Open Access |
subjects | 38/39 38/61 631/1647/48 631/337/2019 Brain cancer Brain tumors Cell cycle Chemotherapy Gene expression Genomes Glioblastoma Humanities and Social Sciences Immune response Medical prognosis Molecular modelling multidisciplinary p53 Protein Patients Prognosis Science Science (multidisciplinary) Signal transduction Surgery Survival analysis |
title | Genome-wide expression profiling of glioblastoma using a large combined cohort |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T15%3A25%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genome-wide%20expression%20profiling%20of%20glioblastoma%20using%20a%20large%20combined%20cohort&rft.jtitle=Scientific%20reports&rft.au=Tang,%20Jing&rft.date=2018-10-10&rft.volume=8&rft.issue=1&rft.spage=15104&rft.epage=12&rft.pages=15104-12&rft.artnum=15104&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-018-33323-z&rft_dat=%3Cproquest_pubme%3E2118311219%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-bd8c9ddca86004a180029fb12d00e705aad54f8b1f78490f6daa159075ab15353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2117920032&rft_id=info:pmid/30305647&rfr_iscdi=true |